October 1, 2018 7:37am

Dow futures are UP +0.79% (+209 points) and NASDAQ futures are UP +0.74% (+57 points)

With the IBB jumping (+0.61%), followed by the XBI (+0.35%), the XLV (+0.62%) and the IWM (+0.56%) indicating an UPSIDE in Monday’s pre-open

 

The oversold will be in a race to be overbought

.

When is it wrong to be right so often? Your portfolio should be profiting from RMi’s analysis!

SUBSCRIBE!

U.S. stock index futures are flying upward

Dow futures are UP +0.79% (+209 points) and NASDAQ futures are UP +0.74% (+57 points)

 

Dow is set to surge 200 points after the US and Canada secure a deal to replace NAFTA

European equities rose during mid-morning deals as investors digested news of a trade agreement between the U.S., Canada and Mexico.

Asia markets were mixed on news of the “deal”

 

Data docket: manufacturing purchasing managers' index figures at 9:45 a.m. ET, followed by ISM manufacturing data and construction spending, both due at 10 a.m. ET.

 

Today’s indications:

  • The iShares Nasdaq Biotechnology (IBB) is indicating a +0.61% UPSIDE in Monday’s pre-market;

  • The SPDR S&P Biotech ETF (XBI) is indicating a +0.35% UPSIDE in Monday’s pre-market;

  • The Health Care Select Sector SPDR ETF (XLV) is indicating a +0.62% UPSIDE in Monday’s pre-open;

  • The iShares Russell 2000 (IWM) is indicating a +0.56% UPSIDE in Monday’s pre-open

 

Henry’omics:

News emerged that Canada and the U.S. had secured a trade deal to replace the current North American Free Trade Agreement (NAFTA). The new accord is expected to be named the United States-Mexico-Canada Agreement or "USMCA" for short!

The agreement will deliver more market access to U.S. dairy farmers, while Canada has effectively capped automobile exports to the States. Both nations, along with Mexico – which agreed to a deal earlier this year – are expected to sign the agreement by the end of November. It would then be passed to Congress <CNBC>.

I always want to know what happened PRIOR to what might happen today – it sets a tone of consequence:

From Friday’s night’s newsletter: “the sector navigates the market’s monthly and quarterly close. Volume has been increasing specifically to the downside yet, a few upside moves also showed significant numbers.”

  • Of the 45 companies covered on Friday; 22 downside equities finished in a range of -0.13% (RGNX) to -5.53% (KOOL -$0.018) while 20 upside equity oscillated from +0.30% (SGMO) to +11.36% (ADRO) with 3  flat closes (OSIR, RENE.L and BCLI );
  • The iShares NASDAQ Biotechnology (IBB): had a five session aggregate of +2.86% - consider an upside spike!
  • In 19 sessions in September (so far) – there were 10 negative closes and 9 positive close;
  • In 21 August sessions – 6 had negative and 15 had positive closes

 

Companies in my headlights – It’s your decision; I provide the idea and context:

… BE prepared for a general rise in VALUE of MANY of our 45 covered companies …

                          IT’S about TIME ….

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.